Logo image of BKD

BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis

USA - NYSE:BKD - US1124631045 - Common Stock

8.59 USD
-0.29 (-3.27%)
Last: 10/10/2025, 9:12:35 PM
8.5 USD
-0.09 (-1.05%)
After Hours: 10/10/2025, 9:12:35 PM
Fundamental Rating

1

Overall BKD gets a fundamental rating of 1 out of 10. We evaluated BKD against 101 industry peers in the Health Care Providers & Services industry. BKD may be in some trouble as it scores bad on both profitability and health. BKD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BKD had negative earnings in the past year.
In the past year BKD had a positive cash flow from operations.
In the past 5 years BKD reported 4 times negative net income.
BKD had a positive operating cash flow in 4 of the past 5 years.
BKD Yearly Net Income VS EBIT VS OCF VS FCFBKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BKD's Return On Assets of -3.95% is on the low side compared to the rest of the industry. BKD is outperformed by 64.36% of its industry peers.
BKD has a Return On Equity of -230.26%. This is in the lower half of the industry: BKD underperforms 79.21% of its industry peers.
With a Return On Invested Capital value of 0.88%, BKD is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.95%
ROE -230.26%
ROIC 0.88%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKD Yearly ROA, ROE, ROICBKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BKD has a Operating Margin (1.94%) which is in line with its industry peers.
BKD's Operating Margin has improved in the last couple of years.
BKD has a Gross Margin (25.98%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BKD has grown nicely.
Industry RankSector Rank
OM 1.94%
PM (TTM) N/A
GM 25.98%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKD Yearly Profit, Operating, Gross MarginsBKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKD is destroying value.
Compared to 1 year ago, BKD has more shares outstanding
Compared to 5 years ago, BKD has more shares outstanding
Compared to 1 year ago, BKD has an improved debt to assets ratio.
BKD Yearly Shares OutstandingBKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKD Yearly Total Debt VS Total AssetsBKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BKD has an Altman-Z score of -0.20. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
BKD has a Altman-Z score of -0.20. This is amonst the worse of the industry: BKD underperforms 80.20% of its industry peers.
BKD has a Debt/Equity ratio of 40.40. This is a high value indicating a heavy dependency on external financing.
BKD has a worse Debt to Equity ratio (40.40) than 84.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 40.4
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACC0.11
WACC8.32%
BKD Yearly LT Debt VS Equity VS FCFBKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

BKD has a Current Ratio of 0.83. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.83, BKD is not doing good in the industry: 84.16% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that BKD may have some problems paying its short term obligations.
BKD's Quick ratio of 0.83 is on the low side compared to the rest of the industry. BKD is outperformed by 77.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
BKD Yearly Current Assets VS Current LiabilitesBKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BKD have decreased strongly by -14.13% in the last year.
Looking at the last year, BKD shows a small growth in Revenue. The Revenue has grown by 3.90% in the last year.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%

3.2 Future

Based on estimates for the next years, BKD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.30% on average per year.
The Revenue is expected to grow by 0.74% on average over the next years.
EPS Next Y8.56%
EPS Next 2Y19.69%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.37%
Revenue Next 2Y-0.13%
Revenue Next 3Y0.74%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKD Yearly Revenue VS EstimatesBKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKD Yearly EPS VS EstimatesBKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKD Price Earnings VS Forward Price EarningsBKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

BKD's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.98
BKD Per share dataBKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

BKD's earnings are expected to grow with 17.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.69%
EPS Next 3Y17.3%

More info and screens

0

5. Dividend

5.1 Amount

BKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKDALE SENIOR LIVING INC

NYSE:BKD (10/10/2025, 9:12:35 PM)

After market: 8.5 -0.09 (-1.05%)

8.59

-0.29 (-3.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners98.97%
Inst Owner Change0%
Ins Owners0.79%
Ins Owner Change-8.95%
Market Cap2.04B
Analysts51.67
Price Target7.65 (-10.94%)
Short Float %5.3%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.95%
Min EPS beat(2)-145.33%
Max EPS beat(2)-30.56%
EPS beat(4)0
Avg EPS beat(4)-69%
Min EPS beat(4)-145.33%
Max EPS beat(4)-25.67%
EPS beat(8)1
Avg EPS beat(8)-43.41%
EPS beat(12)4
Avg EPS beat(12)-13.85%
EPS beat(16)6
Avg EPS beat(16)6.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-1.07%
Revenue beat(12)0
Avg Revenue beat(12)-0.91%
Revenue beat(16)0
Avg Revenue beat(16)-0.97%
PT rev (1m)-3.23%
PT rev (3m)3.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.14%
EPS NY rev (1m)-0.94%
EPS NY rev (3m)-12.69%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF N/A
P/OCF 9.33
P/B 19.36
P/tB 26.13
EV/EBITDA 13.98
EPS(TTM)-1.05
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)0.92
OCFY10.72%
SpS13.44
BVpS0.44
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.95%
ROE -230.26%
ROCE 1.11%
ROIC 0.88%
ROICexc 0.92%
ROICexgc 0.92%
OM 1.94%
PM (TTM) N/A
GM 25.98%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 40.4
Debt/FCF N/A
Debt/EBITDA 9.64
Cap/Depr 163.45%
Cap/Sales 19.46%
Interest Coverage 0.25
Cash Conversion 49.49%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z -0.2
F-Score5
WACC8.32%
ROIC/WACC0.11
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y8.56%
EPS Next 2Y19.69%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%
Revenue Next Year2.37%
Revenue Next 2Y-0.13%
Revenue Next 3Y0.74%
Revenue Next 5YN/A
EBIT growth 1Y24.43%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year535.01%
EBIT Next 3Y90.96%
EBIT Next 5YN/A
FCF growth 1Y-274.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.46%
OCF growth 3YN/A
OCF growth 5Y-5.14%